CNTA · Centessa Pharmaceuticals plc · Executive Compensation
Market Cap
$6.27B
Shares
154.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Saurabh Saha | M.D., Ph.D. Former Chief Executive Officer | $11,877,244 |
| Stephen Kanes | M.D., Ph.D. Chief Medical Officer | $6,812,680 |
| John Crowley | Chief Financial Officer | $3,842,835 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Saurabh Saha | M.D., Ph.D. Chief Executive Officer | $5,563,120 |
| John Crowley | Chief Financial Officer | $4,120,748 |
| Iqbal Hussain | General Counsel | $2,046,325 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Saurabh Saha | M.D., Ph.D. Chief Executive Officer | $2,705,874 |
| Antoine Yver | M.D., M.Sc. Chairman of Development | $1,380,739 |
| David Grainger | Former Chief Innovation Officer | $1,363,599 |
| David Chao | Chief Administrative Officer | $1,317,905 |
| Iqbal Hussain | General Counsel | $1,181,713 |
| John Crowley | Chief Financial Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Saurabh Saha | M.D., Ph.D. Chief Executive Officer | $9,612,230 |
| Gregory Weinhoff | M.D., M.B.A Chief Financial Officer | $3,309,069 |
| David Chao | Chief Administrative Officer | $3,309,069 |
| Antoine Yver | M.D., M.Sc. Chairman of Development | $2,517,232 |
| David Grainger | Former Chief Innovation Officer | $2,447,805 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Antoine Yver | M.D., M.Sc. Executive Vice President andChairman of Development | $17,127,519 |
| Saurabh Saha | M.D., Ph.D. Chief Executive Officer | $16,068,587 |
| Gregory Weinhoff | M.D., M.B.A Chief Financial Officer | $4,043,608 |
| David Chao | Chief Administrative Officer | $3,962,067 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Saurabh Saha | M.D., Ph.D. Chief Executive Officer | — |
| Gregory Weinhoff | M.D., M.B.A Chief Financial Officer | — |
| Antoine Yver | M.D., M.Sc. Executive Vice President andChairman of Development | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kristina Mignon Wright | Director | Appointed | 2026-06-24 |
| Brett Zbar | Director | Terminated | 2026-06-24 |
| Carol Stuckley | Director | Terminated | 2026-06-24 |
| Christopher Stokes | Director | Appointed | 2026-06-24 |
| Samarth Kulkarni | Director | Terminated | 2026-06-24 |
| Mathias Hukkelhoven | Director | Terminated | 2026-06-24 |
| Mary Lynne Hedley | Director | Terminated | 2026-06-24 |
| Francesco De Rubertis | Director | Terminated | 2026-06-24 |
| Raphael Deferiere | Executive Officer | Terminated | 2026-06-24 |
| Arjun Goyal | Director | Terminated | 2026-06-24 |
| Stephen Kanes | Executive Officer | Terminated | 2026-06-24 |
| John Crowley | Executive Officer | Terminated | 2026-06-24 |
| Mario Alberto Accardi | Director | Terminated | 2026-06-24 |
| Mario Alberto Accardi | Chief Executive Officer | Terminated | 2026-06-24 |
| Saurabh Saha | member of the Board | Resigned | 2025-12-11 |
| Saurabh Saha | Chief Executive Officer | Resigned | 2025-12-11 |
| Mario Alberto Accardi | member of the Board of Directors | Appointed | 2025-12-11 |
| Mario Alberto Accardi | Chief Executive Officer | Appointed | 2025-12-11 |
| Raphael Deferiere, CPA | Chief Accounting Officer | Appointed | 2025-05-29 |